rs3792293
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_007217.4(PDCD10):c.-308T>C variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.299 in 154,570 control chromosomes in the GnomAD database, including 7,451 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.30 ( 7355 hom., cov: 33)
Exomes 𝑓: 0.26 ( 96 hom. )
Consequence
PDCD10
NM_007217.4 5_prime_UTR
NM_007217.4 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.18
Publications
10 publications found
Genes affected
PDCD10 (HGNC:8761): (programmed cell death 10) This gene encodes an evolutionarily conserved protein associated with cell apoptosis. The protein interacts with the serine/threonine protein kinase MST4 to modulate the extracellular signal-regulated kinase (ERK) pathway. It also interacts with and is phosphoryated by serine/threonine kinase 25, and is thought to function in a signaling pathway essential for vascular developent. Mutations in this gene are one cause of cerebral cavernous malformations, which are vascular malformations that cause seizures and cerebral hemorrhages. Multiple alternatively spliced variants, encoding the same protein, have been identified. [provided by RefSeq, Jul 2008]
PDCD10 Gene-Disease associations (from GenCC):
- cerebral cavernous malformation 3Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp
- famililal cerebral cavernous malformationsInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 3-167734716-A-G is Benign according to our data. Variant chr3-167734716-A-G is described in ClinVar as Benign. ClinVar VariationId is 590668.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.421 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.300 AC: 45593AN: 152128Hom.: 7339 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
45593
AN:
152128
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.257 AC: 597AN: 2324Hom.: 96 Cov.: 0 AF XY: 0.254 AC XY: 427AN XY: 1684 show subpopulations
GnomAD4 exome
AF:
AC:
597
AN:
2324
Hom.:
Cov.:
0
AF XY:
AC XY:
427
AN XY:
1684
show subpopulations
African (AFR)
AF:
AC:
8
AN:
24
American (AMR)
AF:
AC:
10
AN:
28
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
12
East Asian (EAS)
AF:
AC:
13
AN:
64
South Asian (SAS)
AF:
AC:
7
AN:
38
European-Finnish (FIN)
AF:
AC:
140
AN:
432
Middle Eastern (MID)
AF:
AC:
0
AN:
16
European-Non Finnish (NFE)
AF:
AC:
393
AN:
1626
Other (OTH)
AF:
AC:
26
AN:
84
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
15
31
46
62
77
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.300 AC: 45640AN: 152246Hom.: 7355 Cov.: 33 AF XY: 0.297 AC XY: 22084AN XY: 74430 show subpopulations
GnomAD4 genome
AF:
AC:
45640
AN:
152246
Hom.:
Cov.:
33
AF XY:
AC XY:
22084
AN XY:
74430
show subpopulations
African (AFR)
AF:
AC:
17687
AN:
41538
American (AMR)
AF:
AC:
2853
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
AC:
557
AN:
3472
East Asian (EAS)
AF:
AC:
1558
AN:
5162
South Asian (SAS)
AF:
AC:
607
AN:
4832
European-Finnish (FIN)
AF:
AC:
3359
AN:
10604
Middle Eastern (MID)
AF:
AC:
43
AN:
294
European-Non Finnish (NFE)
AF:
AC:
18260
AN:
68016
Other (OTH)
AF:
AC:
543
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1703
3407
5110
6814
8517
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
450
900
1350
1800
2250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
776
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Jan 17, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
not specified Benign:1
Apr 02, 2018
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.